Concourse Financial Group Securities’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Hold |
0
| – | – | – | 10449 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 10094 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 9865 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 9635 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 9390 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 9169 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 8823 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 8831 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 8639 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 8480 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8285 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8029 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7631 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7290 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6991 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6737 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6501 |
|